A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...
A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...
Morning Overview on MSN
Scientists link 2 cancer hallmarks in a way no one expected
Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...
Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.
The MarketWatch News Department was not involved in the creation of this content. Calgary, Alberta and Amsterdam, Netherlands--(Newsfile Corp. - October 27, 2025) - Zenith Epigenetics Ltd. ("Zenith" ...
Scientists at EPFL and Johns Hopkins uncover the central role of an enzyme in controlling prostate cancer subtypes and ...
Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may ...
Great. Good morning, everyone. I'm Alexandra Byrne. I'm a reporter at GenomeWeb, and I will be your moderator for today's webinar. The title of today's webinar is beyond the genome: Measuring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback